What is NDC 71335-1255?

71335-1255 is the product NDC for Tadalafil, Tadalafil 20 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tadalafil?

242 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tadalafil NDC 71335-1255 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-1255Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-1255Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-1255-1	7133512550171335125501	30 TABLET, FILM COATED in 1 BOTTLE (71335-1255-1)Marketed from Jun 20, 2019
71335-1255-2	7133512550271335125502	10 TABLET, FILM COATED in 1 BOTTLE (71335-1255-2)Marketed from Jun 21, 2019
71335-1255-3	7133512550371335125503	90 TABLET, FILM COATED in 1 BOTTLE (71335-1255-3)Marketed from May 17, 2024
71335-1255-4	7133512550471335125504	5 TABLET, FILM COATED in 1 BOTTLE (71335-1255-4)Marketed from May 17, 2024
71335-1255-5	7133512550571335125505	60 TABLET, FILM COATED in 1 BOTTLE (71335-1255-5)Marketed from May 17, 2024
71335-1255-6	7133512550671335125506	20 TABLET, FILM COATED in 1 BOTTLE (71335-1255-6)Marketed from May 17, 2024
71335-1255-7	7133512550771335125507	15 TABLET, FILM COATED in 1 BOTTLE (71335-1255-7)Marketed from May 17, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tadalafil
Generic name (nonproprietary): tadalafil
Active ingredients: Tadalafil — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208934
Marketing start: Mar 26, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 71335-1255_169c8d84-94fd-4024-b98e-a7184dbe83b1SPL ID 169c8d84-94fd-4024-b98e-a7184dbe83b1SPL set ID a73b0e6f-09fc-42d6-a678-1409ce746bd1RxCUI 402019UNII 742SXX0ICT
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335125501 followed by a unit qualifier and the quantity

Package 71335-1255-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 17, 2024.

Indications (excerpt from the label)

Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED) (1.1) the signs and symptoms of benign prostatic hyperplasia (BPH) (1.2) ED and the signs and symptoms of BPH (ED/BPH) (1.3) If tadalafil tablets are used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks (1.4). 1.1 Erectile Dysfunction Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED). 1.2 Benign Prostatic Hyperplasia Tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). 1.3 Erectile Dysfunction and Benign Prostatic Hyperplasia Tadalafil tablets are indicate…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-1255

What is NDC 71335-1255?: 71335-1255 is the product NDC for Tadalafil, Tadalafil 20 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tadalafil.
What is the active ingredient?: Tadalafil.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tadalafil?: 242 other product NDCs are listed under this name. See all Tadalafil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tadalafil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-781	72603-0781-01
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-782	72603-0782-01
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-783	72603-0783-01
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	NorthStar Rx, LLC	72603-784	72603-0784-01
Tadalafil	Tadalafil 5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4605	70518-4605-00
tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-4083	68788-4083-0168788-4083-0368788-4083-07
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-8039	50090-8039-0050090-8039-0150090-8039-02
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-027	60290-0027-0160290-0027-0260290-0027-03+1 more
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-028	60290-0028-0160290-0028-0260290-0028-03+1 more
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-029	60290-0029-0160290-0029-0260290-0029-03+1 more

All 243 Tadalafil NDCs

Other NDCs under ANDA 208934

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208934
Product	Strength	Form · route	Labeler	Product NDC
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	16714-074
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	16714-075
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	16714-076
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	16714-077
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	47335-009
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	47335-010
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	47335-011
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	47335-012
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7390
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7391
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-8047
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-8157
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1884
Tadalafil	Tadalafil 5 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-541
Tadalafil	Tadalafil 2.5 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-542
Tadalafil	Tadalafil 10 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-543
Tadalafil	Tadalafil 20 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-544